Small Business Grants for Biotech Companies (2026)
You're developing breakthrough biotech, but R&D costs and clinical pathways demand millions—venture capital comes with pressure that doesn't match your mission timeline. Bootstrap Directory gives you access to 1,900+ non-dilutive funding sources for biotech innovators. The NIH (National Institutes of Health) provides $200+ million annually through SBIR and STTR grants supporting drug discovery, diagnostics, biologics, and therapeutic development. NSF Convergence Research grants fund startups at biology and engineering intersections. The National Science Foundation's Biology programs support foundational biotech research. DOE Bioenergy grants support sustainable biological solutions. These programs understand biotech's extended development timelines and high capital needs—providing funding specifically for preclinical research, IND-enabling studies, and early-stage trials without requiring equity. NIH SBIR/STTR grants represent the largest funding source for biotech startups, with the NIH allocating over $1 billion annually across its 24 institutes and centers. The NSF, DARPA, and the Biomedical Advanced Research and Development Authority (BARDA) provide additional grant pathways, while state life sciences agencies in Massachusetts, California, and Maryland offer complementary programs.
Last updated
This guide and matching listings are refreshed from the Bootstrap Directory database as source data changes.
Data sources
Sources include Grants.gov, SAM.gov, SBIR.gov, CareerOneStop, state agencies, universities, and verified organizations.
Refresh cadence
Listings are checked weekly where source data allows, with stale or closed programs removed from public results.
Verification
Always confirm eligibility, deadlines, and award details on the official source or application page before applying.
Get alerts for this search
Create a free account, run the matching search, and save it to get new funding, grant, or training updates.
Featured Opportunities
NIH REACH — Research Evaluation and Commercialization Hubs
DoW Neurofibromatosis Synergistic Idea Award
NIH Director’s New Innovator Award (DP2 Clinical Trial Optional)
Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)
DoW Rare Cancers Concept Award
Engineering Biological and Biomedical Systems (EBBS)
DoW Ovarian Cancer, Clinical Trial Award
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Idea Award
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats
Frequently Asked Questions
What types of grants are available for biotech companies?
Biotech companies can access NIH SBIR Phase I and II grants ($150K-$2M+), STTR funding for academic partnerships, and NSF Convergence Research grants. Grants support drug development, diagnostics, biologics, genetic therapies, and sustainable biotech solutions. Many programs include regulatory guidance and mentorship alongside capital for preclinical and early clinical work.
How do I qualify for biotech grants?
Most biotech grants require you to be a U.S. small business with fewer than 500 employees (or 750 for STTR) and demonstrate significant R&D with scientific merit. NIH SBIR requires Phase I feasibility before Phase II. You'll need preliminary data and a clear development pathway. Bootstrap Directory helps identify programs matching your biotech focus and clinical stage.
When are the deadlines for biotech grants?
NIH SBIR and STTR deadlines occur in February, June, and October annually across most institutes. NSF Convergence Research has annual deadlines typically in September. DOE Bioenergy deadlines vary—Bootstrap Directory tracks all biotech funding cycles so you can plan R&D milestones and grant applications strategically.